To learn more about the experimental drug, ISL/LEN. This includes: Comparing ISL/LEN weekly to B/F/TAF daily and determining which of these study treatments works better for treating HIV infection. Determining how ISL/LEN and B/F/TAF affects the HIV infection in the body. Testing and learning about the safety of ISL/LEN, how well ISL/LEN is tolerated, and how long it stays in the body using physical exam, blood and urine tests, and any symptoms or problems it may create in the study.
To better understand whether people in jail have ever received COVID-19 testing and vaccination and whether they would be will to receive these services in jail and after their release.
The purpose of this project is to understand, from the perspective of formerly incarcerated individuals, the barriers and facilitators that people released from prison experience in establishing and engaging with health care, and how those barriers and facilitators may be impacted by participation in the FIT and FIT Connect transitional health care programs.
To assess the influence of HIV-related and CVD-related variables in the existing WIHS study, including viral load, immune dysfunction, inflammation, metabolic disorders, HIV medications, gut microbiota, and metabolomics, on CVD risk as measured by cIMT.
To learn about more effective ways the health care system in Zambia can care for people with non-communicable diseases (NCDs) who are also living with HIV.
The purpose of this study is to assess ultrasound experience, current use of ultrasound and desire for further training of emergency medicine residents in Lima, Peru. This study also has the purpose of determining perceived barriers to expanding the use of ultrasound
The SELIGO study assesses perceptions of HIV treatment - including long acting injectable antiretroviral therapy (LAI ART) - among people living with HIV infection (PLWH) and HIV healthcare providers (HCPs) to develop strategies and tools to facilitate shared decision-making by patients and provider considering HIV therapy options.
The purpose of this research study is to understand if convalescent plasma is a potential therapy and to understand the immune response to COVID-19 infection. Understanding the immune system's response after infection will help to inform vaccine design and the potential role of antibodies as therapeutics in the setting of COVID-19 infection and disease.
Aim 1: Among key stakeholders in NC impacted by HIV molecular surveillance (HMS) activities, we aim to assess the ethical concerns surrounding the implementation of HMS and related pubic health services and research by: 1a) Characterizing stakeholders' awareness, experiences with, and sources of information AND 1b) Examining perceptions, including perceived risks and benefits and other ethical considerations, and the opportunities for enhancement of community engagement practices Aim 2: To develop a community-engaged partnership framework to promote effective communication and community participation regarding HMS, and related health services and research.
To assess how the Medical Staff of UNC view interventions to prevent COVID acquisition